16 | quinolineIBA
05/2020
-
03/2008 |
8 | N-formyl-13-dihydrocarminomycin (NFD)IBA
02/2019
-
01/2010 |
5 | furanIBA
02/2014
-
01/2010 |
3 | Proteins (Proteins, Gene)FDA Link
08/2023
-
08/2010 |
3 | Antineoplastic Agents (Antineoplastics)IBA
08/2023
-
06/2015 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
03/2023
-
04/2016 |
3 | Caspase 3 (Caspase-3)IBA
03/2023
-
08/2010 |
3 | Particulate MatterIBA
11/2022
-
01/2018 |
3 | AntioxidantsIBA
11/2022
-
01/2016 |
3 | GlucuronidaseIBA
01/2022
-
11/2017 |
3 | pterostilbeneIBA
09/2021
-
01/2017 |
3 | Irinotecan (Camptosar)FDA LinkGeneric
01/2019
-
12/2015 |
3 | DNA (Deoxyribonucleic Acid)IBA
04/2013
-
03/2008 |
2 | Imiquimod (Aldara)FDA LinkGeneric
04/2022
-
10/2018 |
2 | CarcinogensIBA
01/2022
-
01/2021 |
2 | Thalidomide (Thalomid)FDA Link
08/2020
-
10/2018 |
2 | trioctyl phosphine oxide (TOPO)IBA
02/2019
-
08/2010 |
2 | 3',4',7-trihydroxyisoflavoneIBA
01/2018
-
01/2016 |
2 | daidzeinIBA
01/2018
-
01/2016 |
2 | 9- methoxy- 6- (piperazin- 1- yl)- 11H- indeno(1,2- c)quinoline- 11- one O-3-(dimethylamino)propyl oximeIBA
08/2016
-
04/2013 |
2 | CamptothecinIBA
08/2016
-
08/2010 |
2 | Type I DNA Topoisomerases (Topoisomerase I)IBA
08/2016
-
04/2013 |
2 | OximesIBA
11/2013
-
08/2010 |
2 | ErbB Receptors (EGF Receptor)IBA
02/2013
-
06/2010 |
1 | Adenosine Triphosphate (ATP)IBA
03/2023 |
1 | IsoflavonesIBA
04/2022 |
1 | Indicators and Reagents (Reagents)IBA
09/2021 |
1 | Air Pollutants (Pollutants, Air)IBA
09/2021 |
1 | Sarcosine (Methylglycine)IBA
01/2021 |
1 | TransferasesIBA
01/2021 |
1 | CytokinesIBA
08/2020 |
1 | benzyl chlorideIBA
08/2020 |
1 | CurcuminIBA
07/2020 |
1 | PhytochemicalsIBA
02/2019 |
1 | Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2019 |
1 | DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2019 |
1 | Interleukin-6 (Interleukin 6)IBA
10/2018 |
1 | Interleukin-8 (Interleukin 8)IBA
10/2018 |
1 | Environmental Pollutants (Pollutants, Environmental)IBA
01/2018 |
1 | EnzymesIBA
11/2017 |
1 | GlucuronidesIBA
11/2017 |
1 | Isoniazid (Ftivazide)FDA LinkGeneric
06/2017 |
1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2017 |
1 | QuinolonesIBA
04/2016 |
1 | Melanins (Melanin)IBA
01/2016 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
12/2015 |
1 | Antimitotic AgentsIBA
01/2015 |
1 | 1- (4- (furo(2,3- b)quinolin- 4- ylamino)phenyl)ethanoneIBA
01/2015 |
1 | 2-furanylvinylquinolineIBA
01/2015 |
1 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2014 |
1 | furano-1,2-naphthoquinoneIBA
05/2014 |
1 | Bromodeoxyuridine (BrdU)IBA
04/2013 |
1 | beta-lapachoneIBA
01/2013 |
1 | fosbretabulin (combretastatin A4)IBA
11/2012 |
1 | Prostaglandins EIBA
05/2012 |
1 | NF-kappa B (NF-kB)IBA
09/2010 |
1 | p38 Mitogen-Activated Protein KinasesIBA
09/2010 |
1 | AminesIBA
08/2010 |
1 | PiperazineIBA
08/2010 |
1 | HydrogenIBA
08/2010 |
1 | Histones (Histone)IBA
08/2010 |
1 | hydroxide ionIBA
08/2010 |
1 | Cytotoxins (Cytolysins)IBA
08/2010 |